Benamouzig R - Search Results

1

Aspirin to prevent colorectal cancer: time to act?

Benamouzig R, Uzzan B. Benamouzig R, et al. Lancet. 2010 Nov 20;376(9754):1713-4. doi: 10.1016/S0140-6736(10)61509-7. Epub 2010 Oct 21. Lancet. 2010. PMID: 20970845 No abstract available.

2

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature.

Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY. Des Guetz G, et al. Among authors: benamouzig r. Br J Cancer. 2006 Jun 19;94(12):1823-32. doi: 10.1038/sj.bjc.6603176. Br J Cancer. 2006. PMID: 16773076 Free PMC article.

3

Identification of a functional EGF-R/p60c-src/STAT3 pathway in colorectal carcinoma: analysis of its long-term prognostic value.

Hbibi AT, Lagorce C, Wind P, Spano JP, Des Guetz G, Milano G, Benamouzig R, Rixe O, Morere JF, Breau JL, Martin A, Fagard R. Hbibi AT, et al. Among authors: benamouzig r. Cancer Biomark. 2008;4(2):83-91. doi: 10.3233/cbm-2008-4204. Cancer Biomark. 2008. PMID: 18503159

4

Small bowel carcinoma revealing HNPCC syndrome.

Babba T, Schischmanoff O, Lagorce C, Wind P, Des Guetz G, Aparicio T, Benamouzig R. Babba T, et al. Among authors: benamouzig r. Gastroenterol Clin Biol. 2010 Apr-May;34(4-5):325-8. doi: 10.1016/j.gcb.2010.04.007. Gastroenterol Clin Biol. 2010. PMID: 20627638

5

Invitation letter with a standardized form is a reliable tool to exclude increased risk patients from organized fecal immunological testing-based colorectal cancer screening program.

Sportes A, Catajar N, Charles S, Bejou B, Mary F, Sabaté JM, Le Mab G, Benamouzig R. Sportes A, et al. Among authors: benamouzig r. Dig Liver Dis. 2018 Dec;50(12):1339-1342. doi: 10.1016/j.dld.2018.02.008. Epub 2018 Mar 6. Dig Liver Dis. 2018. PMID: 29571900

6

[Colorectal cancer chemoprophylaxis].

Soualy A, Benamouzig R. Soualy A, et al. Among authors: benamouzig r. Rev Prat. 2019 Feb;69(2):123-127. Rev Prat. 2019. PMID: 30983206 Review. French. No abstract available.

7

[Hereditary non polyposis colon cancer: diagnosis and management].

Schischmanoff PO, Lagorce C, Wind P, Benamouzig R. Schischmanoff PO, et al. Among authors: benamouzig r. Gastroenterol Clin Biol. 2005 Oct;29(10):1028-34. doi: 10.1016/s0399-8320(05)88179-5. Gastroenterol Clin Biol. 2005. PMID: 16435511 Review. French. No abstract available.

8

Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.

Benamouzig R, Uzzan B, Little J, Chaussade S. Benamouzig R, et al. Curr Top Med Chem. 2005;5(5):493-503. doi: 10.2174/1568026054201631. Curr Top Med Chem. 2005. PMID: 15974944 Review.

9

Is colorectal cancer an avoidable disease nowadays?

Benamouzig R. Benamouzig R. Best Pract Res Clin Gastroenterol. 2004;18 Suppl:107-11. doi: 10.1016/j.bpg.2004.06.019. Best Pract Res Clin Gastroenterol. 2004. PMID: 15588802 Review.

10

Calcium supplementation for preventing colorectal cancer: where do we stand?

Benamouzig R, Chaussade S. Benamouzig R, et al. Lancet. 2004 Oct 2-8;364(9441):1197-9. doi: 10.1016/S0140-6736(04)17156-0. Lancet. 2004. PMID: 15464166 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results